SEARCH RESULTS FOR IPA
QIAGEN IPA
From Signature to Strategy: Drug Repurposing and Indication Expansion with...
Discover how QIAGEN Ingenuity Pathway Analysis (IPA) and OmicSoft Studio empower...
QIAGEN IPA
Discover biomarkers, validate targets and identify variants with QDI software
Learn how to leverage solutions from QIAGEN Digital Insights to discover biomarkers,...
QIAGEN IPA
Discovery from public data (GEO, SRA and more) using Ingenuity Pathway Analysis
Per user feedback, we are hosting a comprehensive training on how to effectively use...
QIAGEN IPA
Make discoveries from public data (GEO, SRA and more) using QIAGEN Ingenuity...
Slides from this training: https://qiagen.showpad.com/share/TgxuabZORvDS3uLGCJRGN You...
QIAGEN IPA
Discovery from public oncological data using QIAGEN Omicsoft OncoLand and...
In this 90-minute training, we will discuss how to discover and validate biomarkers as...
QIAGEN IPA
Decoding neuropathies with TDP-43 and CRISPR
Neurodegenerative disorders linked to protein dysfunction are difficult to study...
QIAGEN IPA
Exploration of deeply curated single-cell data with OmicSoft Explorer
QIAGEN OmicSoft Explorer is your portal to thousands of deeply curated and integrated...
QIAGEN IPA
Grazing for insights: Leveraging regulatory neutrophils toward bovine...
Neutrophils, known for killing microbes, can be both beneficial and harmful during a...
QIAGEN IPA
Uncover molecular drivers of the tumor microenvironment using curated data...
Understanding the tumor microenvironment (TME) presents a major challenge for biopharma...
QIAGEN IPA
QIAGEN Ingenuity Pathway Analysis - ID mapping strategies
While Ingenuity Pathway Analysis (IPA) accepts wide range of identifiers (gene,...
QIAGEN IPA
Interpretation of spatial transcriptomics data using QIAGEN Ingenuity Pathway...
This 90-minute training session is about how QIAGEN Ingenuity Pathway Analysis (IPA)...
QIAGEN IPA
New feature Navigating datasets with OmicSoft Explorer
Meet OmicSoft Explorer, a new feature included with your QIAGEN IPA/OmicSoft...